Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

M. van den Broek; N.B. Klarenbeek; L. Dirven; D. van Schaardenburg; H.M.J. Hulsmans; P.J.S.M. Kerstens; T.W.J. Huizinga; B.A.C. Dijkmans; C.F. Allaart

doi:10.1136/ard.2010.147751

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

M. van den Broek, N.B. Klarenbeek, L. Dirven, D. van Schaardenburg, H.M.J. Hulsmans, P.J.S.M. Kerstens, T.W.J. Huizinga, B.A.C. Dijkmans, C.F. Allaart

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1389-1394
Journal	Annals of the Rheumatic Diseases
Volume	70
Issue number	8
DOIs	https://doi.org/10.1136/ard.2010.147751
Publication status	Published - 2011

Access to Document

10.1136/ard.2010.147751

Cite this

van den Broek, M., Klarenbeek, N. B., Dirven, L., van Schaardenburg, D., Hulsmans, H. M. J., Kerstens, P. J. S. M., Huizinga, T. W. J., Dijkmans, B. A. C., & Allaart, C. F. (2011). Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Annals of the Rheumatic Diseases, 70(8), 1389-1394. https://doi.org/10.1136/ard.2010.147751

@article{efef487cf0ec4b449db351ed790e8932,

title = "Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study",

author = "{van den Broek}, M. and N.B. Klarenbeek and L. Dirven and {van Schaardenburg}, D. and H.M.J. Hulsmans and P.J.S.M. Kerstens and T.W.J. Huizinga and B.A.C. Dijkmans and C.F. Allaart",

year = "2011",

doi = "10.1136/ard.2010.147751",

language = "Undefined/Unknown",

volume = "70",

pages = "1389--1394",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "8",

}

van den Broek, M, Klarenbeek, NB, Dirven, L, van Schaardenburg, D, Hulsmans, HMJ, Kerstens, PJSM, Huizinga, TWJ, Dijkmans, BAC & Allaart, CF 2011, 'Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study', Annals of the Rheumatic Diseases, vol. 70, no. 8, pp. 1389-1394. https://doi.org/10.1136/ard.2010.147751

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. / van den Broek, M.; Klarenbeek, N.B.; Dirven, L. et al.
In: Annals of the Rheumatic Diseases, Vol. 70, No. 8, 2011, p. 1389-1394.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

AU - van den Broek, M.

AU - Klarenbeek, N.B.

AU - Dirven, L.

AU - van Schaardenburg, D.

AU - Hulsmans, H.M.J.

AU - Kerstens, P.J.S.M.

AU - Huizinga, T.W.J.

AU - Dijkmans, B.A.C.

AU - Allaart, C.F.

PY - 2011

Y1 - 2011

U2 - 10.1136/ard.2010.147751

DO - 10.1136/ard.2010.147751

M3 - Article

C2 - 21515916

SN - 0003-4967

VL - 70

SP - 1389

EP - 1394

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 8

ER -

van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HMJ, Kerstens PJSM et al. Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Annals of the Rheumatic Diseases. 2011;70(8):1389-1394. doi: 10.1136/ard.2010.147751